Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

Antibiotics among 7 new drugs backed by EMA

Antibiotics among 7 new drugs backed by EMA The Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval. ... Other recommendations. The Medicines Company had a second new drug feature among the list of CHMP positive opinions.

FDA backs Cubist's antibiotic Zerbaxa

FDA backs Cubist's antibiotic Zerbaxa The ruling opened the door for generic competition to Cubicin in 2016 rather than 2018, which according to analysts could cost the company up to $2bn in lost sales. ... In addition to Sivextro, the agency also gave a green light this year to Durata

FDA approves antibacterial skin drug Orbactiv

FDA approves antibacterial skin drug Orbactiv US regulator authorises Medicines Company's treatment for ABSSSI. The Food and Drug Administration has approved antibacterial drug Orbactiv (oritavancin) to treat adults with acute bacterial skin and skin structure infections ... ABSSSI). Manufactured by

Cubist gets green light from FDA for new antibiotic Sivextro

Cubist gets green light from FDA for new antibiotic Sivextro 2020. Other drugs in development to treat ABSSSIs include Furiex Pharmaceuticals' avarofloxacin (phase III), Melinta Therapeutics' delafloxacin (phase III) and The Medicines Company's oritavancin (filed for approval in the US). ... Cubist's Dr Gilman

Cell wall inhibitors for bacterial infections

Cell wall inhibitors for bacterial infections The same company is also developing the oral FDC cefpodoxime/ofloxacin for the treatment of patients with respiratory tract infections and typhoid, which is also in phase III development in India. ... Gram-positive infections. An IV formulation of

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics